News

Spooky season is big business in the retail world, even as consumers trim their spending overall amid persistent inflation and other concerns.

The National Retail Federation estimates Halloween

A well-known giant in the U.S. energy sector is capturing significant new attention. Energy Transfer (NYSE: ET), a long-established pipeline operator, is experiencing a notable surge in investor

On Oct. 6, the stock market rendered a clear and stunning verdict on the future of Advanced Micro Devices (NASDAQ: AMD). In a single session, AMD’s stock price jumped by over 23% to close at

Pfizer Inc. (NYSE: PFE) made a strong move higher after it became the first drug manufacturer to sign on as part of the TrumpRx platform. PFE stock is up nearly 14% since its closing price of

The onset of Q3 earnings season is just around the corner, and it looks like it will be a good one. Not only is there an outlook for S&P 500 (NYSEARCA: SPY) earnings growth and sequential

As the AI arms race accelerates, Advanced Micro Devices (NASDAQ: AMD) is gaining ground in a market long dominated by NVIDIA. Its recent deal with OpenAI adds weight to the view that AMD stock

Dividend Aristocrats are attractive investments due to their reliable cash flow, consistent dividend payments, and annual dividend distribution increases. There is no better time to buy these

Downgrades, like everything in the stock market, are relative. A downgrade or price target reduction for a high-quality stock isn’t a game-ending move for investors.

The most likely outcome is

Pfizer (NYSE: PFE) is no stranger to income investors. The drugmaker, famous for treatments including Lipitor, Viagra, and Zoloft, has now increased its dividend payout for 16 consecutive years

After tanking in early August, the world’s most valuable pharmaceutical stock has roared back with a vengeance. That firm is Eli Lilly and Company (NYSE: LLY), the maker of the wildly popular

With many stocks looking overvalued, many investors may be tempted to sell. However, there are several factors to consider before taking profits:

• Time horizon – when an investor will need the

Insider sales are common in public companies, but investors shouldn't ignore them, especially when unusually high. This may signal insiders view shares as overvalued, a bearish sign. Still

When investors hear that a company will lower prices on its products, their instinctive reaction is to expect a sequential decline in margins and profits, which is not entirely incorrect. However